Evidence map›Paper›PMID 30117204›Full record

ReviewPhytotherapy research : PTR2018

Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review.

Giulia Pastorino, Laura Cornara, Sónia Soares, Francisca Rodrigues, M Beatriz P P Oliveira

Registry-linked trialAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05664906 (Evaluating Efficacy and Safety of Chinese Medicine Oral Rinse in Treating and Preventing Irradiated Oral Mucositis in Head-and-Neck Cancer Patients - a Pilot Trial), which is not on this map. Cited by 283 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
283citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05664906 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluating Efficacy and Safety of Chinese Medicine Oral Rinse in Treating and Preventing Irradiated Oral Mucositis in Head-and-Neck Cancer Patients - a Pilot Trial

TypeinterventionalSponsorChinese University of Hong KongRan2023 to 2024Enrolled40ConditionsHead and Neck Neoplasms, Oral Mucositis (Ulcerative) Due to Radiation, Chinese Medicine Oral RinseArmsChinese Medicine Oral Rinse Formula-I (CMORF-I), Standard Care, Placebo
3 · Its place in the literature

Who cites it

283 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. The Green Path to Liver Health: Herbal Solutions for Non-alcoholic Steatohepatitis.Cardiovascular & hematological disorders drug targets · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Glycyrrhizin alleviatesJournal of thoracic disease · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

223 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giulia PastorinoDISTAV, University of Genoa, Genoa, Italy.
Laura CornaraDISTAV, University of Genoa, Genoa, Italy.ORCID http://orcid.org/0000-0001-9154-7789
Sónia SoaresLAQV/REQUIMTE, Faculty of Pharmacy, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0001-5280-5490
Francisca RodriguesLAQV/REQUIMTE, Faculty of Pharmacy, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0001-8803-0041
M Beatriz P P OliveiraLAQV/REQUIMTE, Faculty of Pharmacy, University of Porto, Porto, Portugal.ORCID http://orcid.org/0000-0002-6767-6596

Funding

European Regional Development Fund NORTE-01-0145-FEDER-000011FCT/MECFundação para a Ciência e a Tecnologia Operação NORTE-01-0145-FEDER-000011Italian Ministry of Education, Universities and ResearchMinistério da Educação e Ciência
6 · The paper itself

Abstract

In the last years, consumers are paying much more attention to natural medicines and principles, mainly due to the general sense that natural compounds are safe. On the other hand, there is a growing demand by industry for plants used in traditional medicine that could be incorporated in foods, nutraceuticals, cosmetics, or even pharmaceuticals. Glycyrrhiza glabra Linn. belongs to the Fabaceae family and has been recognized since ancient times for its ethnopharmacological values. This plant contains different phytocompounds, such as glycyrrhizin, 18β-glycyrrhetinic acid, glabrin A and B, and isoflavones, that have demonstrated various pharmacological activities. Pharmacological experiments have demonstrated that different extracts and pure compounds from this species exhibit a broad range of biological properties, including antibacterial, anti-inflammatory, antiviral, antioxidant, and antidiabetic activities. A few toxicological studies have reported some concerns. This review addresses all those issues and focuses on the pharmacological activities reported for G. glabra. Therefore, an updated, critical, and extensive overview on the current knowledge of G. glabra composition and biological activities is provided here in order to explore its therapeutic potential and future challenges to be utilized for the formulation of new products that will contribute to human well-being.

Indexed as

AnimalsAnti-Bacterial AgentsAntioxidantsAntiviral AgentsEnzyme InhibitorsEthnopharmacologyGlycyrrhizaGlycyrrhizic AcidHumansHypoglycemic AgentsMedicine, TraditionalPhytochemicalsPlant ExtractsAnti-Bacterial AgentsAntioxidantsAntiviral AgentsEnzyme InhibitorsGlycyrrhizic AcidHypoglycemic AgentsPhytochemicalsPlant ExtractsGlycyrrhiza glabrapharmacologyphytochemistrytoxicologytraditional use

Identifiers

PMID30117204
PMCPMC7167772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.